Literature DB >> 14637084

Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration.

C A Tobias1, J S Shumsky, M Shibata, M H Tuszynski, I Fischer, A Tessler, M Murray.   

Abstract

Ex vivo gene therapy, utilizing modified fibroblasts that deliver BDNF or NT-3 to the acutely injured spinal cord, has been shown to elicit regeneration and recovery of function in the adult rat. Delayed grafting into the injured spinal cord is of great clinical interest as a model for treatment of chronic injury but may pose additional obstacles that are not present after acute injury, such as the need to remove an established scar, increased retrograde cell loss and/or atrophy, and diminished capacity for regeneration by neurons which may be doubly injured. The purpose of the present study was to determine if delayed grafting of neurotrophin secreting fibroblasts would have anatomical effects similar to those seen in acute grafting models. We grafted a mixture of BDNF and NT-3 producing fibroblasts or control fibroblasts into a complete unilateral cervical hemisection after a 6-week delay. Fourteen weeks after delayed grafting we found that both the neurotrophin secreting fibroblasts and control fibroblasts survived, but that only the neurotrophin secreting grafts provided a permissive environment for host axon growth, as indicated by immunostaining for RT-97, a marker for axonal neurofilaments, GAP-43, a marker for elongating axons, CGRP, a marker for dorsal root axons, and 5-HT, a marker for raphe spinal axons, within the graft. Anterograde tracing of the uninjured vestibulospinal tract showed growth into neurotrophin producing transplants but not into control grafts, while anterograde tracing of the axotomized rubrospinal tract showed a small number of regenerating axons within the genetically modified grafts, but none in control grafts. The neurotrophin expressing grafts, but not the control grafts, significantly reduced retrograde degeneration and atrophy in the injured red nucleus. Grafts of BDNF + NT-3 expressing fibroblasts delayed 6 weeks after injury therefore elicit growth from intact segmental and descending spinal tracts, stimulate modest regenerative growth by rubrospinal axons, and partially rescue axotomized supraspinal neurons and protect them from atrophy. The regeneration of rubrospinal axons into delayed transplants was much less than has been observed when similar transplants were placed acutely into a lateral funiculus or, after a 4-week delay, into a hemisection lesion. This suggests that the regenerative capacity of chronically injured red nucleus neurons was markedly diminished. The increased GAP43 reactivity in the corticospinal tracts ipsilaterally and contralaterally to the combination grafts suggests that these axons remain responsive to the neurotrophins, that the neurotrophins may stimulate both regenerative and sprouting responses, and that the grafted cells continue to secrete the neurotrophins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14637084     DOI: 10.1016/s0014-4886(03)00394-7

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  72 in total

1.  Axonal regeneration induced by blockade of glial inhibitors coupled with activation of intrinsic neuronal growth pathways.

Authors:  Xingxing Wang; Omar Hasan; Alexander Arzeno; Larry I Benowitz; William B J Cafferty; Stephen M Strittmatter
Journal:  Exp Neurol       Date:  2012-06-21       Impact factor: 5.330

2.  Differential regulation of axon outgrowth and reinnervation by neurotrophin-3 and neurotrophin-4 in the hippocampal formation.

Authors:  Daniel Hechler; Francesco Boato; Robert Nitsch; Sven Hendrix
Journal:  Exp Brain Res       Date:  2010-07-17       Impact factor: 1.972

Review 3.  Gene therapy approaches to enhancing plasticity and regeneration after spinal cord injury.

Authors:  Steffen Franz; Norbert Weidner; Armin Blesch
Journal:  Exp Neurol       Date:  2011-01-31       Impact factor: 5.330

4.  Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury.

Authors:  Sara J Taylor; Ephron S Rosenzweig; John W McDonald; Shelly E Sakiyama-Elbert
Journal:  J Control Release       Date:  2006-06-22       Impact factor: 9.776

Review 5.  The role of cyclic AMP signaling in promoting axonal regeneration after spinal cord injury.

Authors:  Sari S Hannila; Marie T Filbin
Journal:  Exp Neurol       Date:  2007-08-27       Impact factor: 5.330

6.  In vitro analysis of PNIPAAm-PEG, a novel, injectable scaffold for spinal cord repair.

Authors:  Noelle Comolli; Birgit Neuhuber; Itzhak Fischer; Anthony Lowman
Journal:  Acta Biomater       Date:  2008-10-26       Impact factor: 8.947

7.  Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation.

Authors:  Roberta Brambilla; Trikaldarshi Persaud; Xianchen Hu; Shaffiat Karmally; Valery I Shestopalov; Galina Dvoriantchikova; Dmitry Ivanov; Lubov Nathanson; Scott R Barnum; John R Bethea
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Functional recovery of stepping in rats after a complete neonatal spinal cord transection is not due to regrowth across the lesion site.

Authors:  N J K Tillakaratne; J J Guu; R D de Leon; A J Bigbee; N J London; H Zhong; M D Ziegler; R L Joynes; R R Roy; V R Edgerton
Journal:  Neuroscience       Date:  2009-12-17       Impact factor: 3.590

9.  Pericontusion axon sprouting is spatially and temporally consistent with a growth-permissive environment after traumatic brain injury.

Authors:  Neil G Harris; Yevgeniya A Mironova; David A Hovda; Richard L Sutton
Journal:  J Neuropathol Exp Neurol       Date:  2010-02       Impact factor: 3.685

10.  Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury.

Authors:  Philip J Johnson; Stanley R Parker; Shelly E Sakiyama-Elbert
Journal:  Biotechnol Bioeng       Date:  2009-12-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.